Barbara Martino
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Barbara Martino has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Alfredo Gabriele Nanni
Department of Neurology, A. Perrino’s Hospital, 72100 Brindisi, Italy
1 shared publication Andrea Beghi
Neurotology and Vestibular Rehabilitation Clinic—Centro di Medicina, 44124 Ferrara, Italy
1 shared publication- Eliana Filipponi
Department of Clinical Sciences and Community Health, University of Milan, Via della Commenda 19, 20122 Milan, Italy
1 shared publication - Federica Di Berardino
Department of Clinical Sciences and Community Health, University of Milan, 20122 Milan, Italy
1 shared publication - Giulio Dehesh
Independent Researcher, Via Chiesanuova 239, 35136 Padova, Italy
1 shared publication - Lorenzo Collino
Department of Clinical Sciences and Community Health, University of Milan, Via della Commenda 19, 20122 Milan, Italy
1 shared publication
Latest Publications
- Open Access
- 17 March 2026
- Published by MDPI AG in Audiology Research
- Vol. 16 (2) , 45
A New Wearable System for Postural Balance Assessment: Comparison with EquiTest and Static Posturography in Healthy Adults
Background: Objective assessment of postural control is central to the clinical evaluation of vestibular disorders. Although force-platform-based posturography is considered the gold standard, its use may be limited by cost and infrastructural requirements. Wearable inertial measurement units (IMUs) represent a promising alternative; however, their clinical validation should account for intrinsic differences in measurement paradigms rather than strict metric equivalence. Objective: To preliminarily evaluate the within-session reliability of a wearable IMU-based medical device for balance assessment (Gravity), and its agreement with established static (SBP) and computerised dynamic posturographic systems (CDP) in healthy subjects. Methods: Sixty-three healthy adults were enrolled in two independent method comparison studies: a wearable IMU-based balance system versus a static stabilometric platform (GRAVITY vs. SVEP; n = 42) and a wearable IMU-based balance system versus computerised dynamic posturography (Gravity vs. EquiTest; n = 21). Gravity measurements were obtained simultaneously with reference systems across standardised sensory conditions. Within-session reliability and method agreement were assessed. Results: Within-session reliability of Gravity was outcome-dependent. Length-based components demonstrated higher repeatability (ICC (single) = 0.25–0.35; ICC (average) = 0.41–0.52), with narrower limits of agreement (LoA = ±9–12%) and lower measurement error (SEM = 3.3–4.3%). In comparison with SBP, length-based measures exhibited narrower limits (LoA = ±12–17) and more consistent relationships. Comparison with CDP revealed moderate agreement for composite and preferential scores (LoA: −2.20–7.07; −5.54–8.12). Conclusions: Gravity sensor may represent a clinically meaningful, outcome-dependent performance, with superior reliability and comparability for length-based postural measures compared with area-based measures. The device could provide balance assessments compatible with both static and dynamic posturographic systems, accounting for physiological variability. These findings support the potential clinical use of wearable IMU-based posturography, particularly in settings where conventional force-platform systems are not readily available, and warrant further validation in larger, more clinically diverse populations.
- 17 March 2026
- Published by MDPI AG in Audiology Research
- Vol. 16 (2) , 45
Open AccessA New Wearable System for Postural Balance Assessment: Comparison with EquiTest and Static Posturography in Healthy Adults
Background: Objective assessment of postural control is central to the clinical evaluation of vestibular disorders. Although force-platform-based posturography is considered the gold standard, its use may be limited by cost and infrastructural requirements. Wearable inertial measurement units (IMUs) represent a promising alternative; however, their clinical validation should account for intrinsic differences in measurement paradigms rather than strict metric equivalence. Objective: To preliminarily evaluate the within-session reliability of a wearable IMU-based medical device for balance assessment (Gravity), and its agreement with established static (SBP) and computerised dynamic posturographic systems (CDP) in healthy subjects. Methods: Sixty-three healthy adults were enrolled in two independent method comparison studies: a wearable IMU-based balance system versus a static stabilometric platform (GRAVITY vs. SVEP; n = 42) and a wearable IMU-based balance system versus computerised dynamic posturography (Gravity vs. EquiTest; n = 21). Gravity measurements were obtained simultaneously with reference systems across standardised sensory conditions. Within-session reliability and method agreement were assessed. Results: Within-session reliability of Gravity was outcome-dependent. Length-based components demonstrated higher repeatability (ICC (single) = 0.25–0.35; ICC (average) = 0.41–0.52), with narrower limits of agreement (LoA = ±9–12%) and lower measurement error (SEM = 3.3–4.3%). In comparison with SBP, length-based measures exhibited narrower limits (LoA = ±12–17) and more consistent relationships. Comparison with CDP revealed moderate agreement for composite and preferential scores (LoA: −2.20–7.07; −5.54–8.12). Conclusions: Gravity sensor may represent a clinically meaningful, outcome-dependent performance, with superior reliability and comparability for length-based postural measures compared with area-based measures. The device could provide balance assessments compatible with both static and dynamic posturographic systems, accounting for physiological variability. These findings support the potential clinical use of wearable IMU-based posturography, particularly in settings where conventional force-platform systems are not readily available, and warrant further validation in larger, more clinically diverse populations.